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This paper includes commentaries on outcomes of esophageal surgery, including the mechanisms by which fun-
doduplication improves lower esophageal sphincter (LES) pressure; the efficacy of the LinxTM management system
in improving LES function; the utility of radiologic characterization of antireflux valves following surgery; the
correlation between endoscopic findings and reported symptoms following antireflux surgery; the links between
laparoscopic sleeve gastrectomy and decreased LES pressure, endoscopic esophagitis, and gastroesophageal reflux
disease (GERD); the less favorable outcomes following fundoduplication among obese patients; the application of
bioprosthetic meshes to reinforce hiatal repair and decrease the incidence of paraesophageal hernia; the efficacy of
endoluminal antireflux procedures, and the limited efficacy of revisional antireflux operations, underscoring the
importance of good primary surgery and diligent work-up to prevent the necessity of revisional procedures.
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Concise summaries
 Improvement of the lower esophageal sphinc-
ter (LES) basal pressure has been initially sug-
gested as the most relevant effect of fundopli-
cation. However, length of the sphincter has
a proved effect on the LES pressure (LESP)
required to establish competence, and in addi-
tion, increased sphincter length decreases the
effect of gastric wall tension in opening the
sphincter, that is, more gastric distension can
occur before an opening pressure is reached.
Another mechanism of action of antireflux
surgery is represented by the gastroesophageal
flap, which tends to occlude the lumen of
the distal esophagus as intragastric pressure
rises. Restriction of the caliber of the distal
esophagus is another mechanism that can ex-
plain the antireflux effect of an operation. In
addition, fundoplicationprevents complete re-
laxation of the LES upon swallowing and de-
creases the triggering of transient LES relax-
ations (TLESRs). The crural repair which is
usually combined with the antireflux proce-
dure has the potential to prevent mediastinal
migration of the wrap and may add strength
to the antireflux barrier.
 The LinxTM reflux management system is de-
signed to provide a permanent solution to
gastroesophageal reflux disease (GERD) by
augmenting the physiologic function of the
LES with a simple and reproducible laparo-
scopic procedure that does not alter gastric
anatomy and, importantly, is easily reversible
if necessary. In order for reflux to occur, gas-
tric pressuresmust overcomeboth the patient’s
native LESP and the magnetic bonds of the
device. This new reflux management system
can interrupt distraction of the LES by gastric
wall tension and therefore increase the intra-
gastric pressure required to open the cardia. It
is speculated that this effect may be sufficient
to prevent unfolding of the LES and to provide
physiological reflux control in patients with
early disease and small hiatal hernia (HH).
 The modern barium swallow emphasizes mo-
tion recording (video), uses a tightly con-
trolled examination protocol, and requires
an understanding of esophageal physiology.
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Normal postfunduplication findings on con-
trast material should be a tapered narrow-
ing of the distal esophagus that extends for
2–3 cm. The valve should be located below the
diaphragmatic hiatus and the wrap is seen as
a smooth filling defect in the fundus, with
the barium column passing through the cen-
ter of an image that mimics a pseudotumor.
Assessment of the anatomic outcome is essen-
tial and should be done systematically because
symptomatic outcome may underestimate the
true recurrence rate. Complications are gen-
erally diagnosed with barium swallow exami-
nation, and include too-tight fundoplication
with delayed clearance, complete or partial
fundoplication dehiscence, recurrent hernia,
and slipped wrap.
 Correlation of the endoscopic aspect of the
antireflux barrier with symptoms, manome-
try, and 24-h pH studies show that there is a
very good correlation between a normal post-
operative valve with symptoms and functional
studies, but a poorer correlation when a defec-
tive value is present.
 Laparoscopic sleeve gastrectomy is recog-
nized as an option for surgical treatment
for obesity. Its consequences on the anatomy
of the esophagogastric junction (EGJ) may
lead to gastroesophageal dysmotility and
decrease of LESP, probably due to par-
tial resection of the sling fibers during the
operation.
 The outcomes and durability of fundoplica-
tion in the setting of severe obesity are not
as favorable as those in not severely obese
patients. Correlation between failures of an-
tireflux procedures and increasing body mass
index (BMI) is probably due to the relative in-
crease in intra-abdominal pressure associated
with obesity, thus predisposing to breakdown
of the fundoplication but not necessarily to a
wrap herniation.
 Theuse of prosthetic andbioprostheticmeshes
as a reinforcement of the hiatal repair has
gained the acceptance of different groups in
order to decrease the incidence of recurrence
after repair of paraesophageal hernia (PEH).
To lower the risk of complications, new bio-
prosthetic meshes have been used to reinforce
the hiatal closure. These biomaterials act as an
extracellular matrix scaffold to augment the
native tissue healing and regeneration: they
are pliable and temporary, by nature, so they
should not have the associated risks of the non-
absorbable meshes. The use of these biomate-
rials appears to be safe, and it is an effective
alternative to the use of synthetic mesh for re-
pair of PEH.
 All endoluminal treatments for GERD re-
sult in a moderate improvement in symptom
scores, some decrease in medication use, but
no correction of objective acid exposure test-
ing in 70% or so of patients, with controversy
over what exactly the appropriate endpoint
of GERD treatment should be—patient sat-
isfaction or a normal objective measurement.
Current endoluminal devices and procedures
have many patient exclusions, are disliked by
the medical insurance community, and do not
normalize pH in the majority of patients. On
the other hand, they do markedly improve pa-
tients’ symptoms and may make them easier
to control medically.
 The cause of failure of antireflux operations
is, in the majority of patients, an anatomic ab-
normality such as recurrentHHwithwrapmi-
gration or disruption/disconfiguration of the
wrap. In approximately 2% of patients, failure
is found to be due to a previously unknown
motility disorder. Revisional operations have
a higher mortality and morbidity than pri-
mary surgery, and their outcome is less favor-
able than after primary repair. Quality-of-life
scores are however generally improved.
1. How does antireflux surgery correct
lower esophageal sphincter dysfunction?
Luigi Bonavina and Stefano Siboni
luigi.bonavina@unimi.it
Antireflux surgery has developed on an empiri-
cal basis without full understanding of the patho-
physiological determinants of antireflux compe-
tence. Rudolf Nissen serendipitously discovered
that wrapping the gastric fundus around the
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anastomosis to protect from anastomotic leakage
after esophagectomy was also effective to prevent
gastroesophageal reflux (GER). By 1960, the Nissen
fundoplication was used in patients with HH and
reflux esophagitis, and has then become the gold
standard of surgical therapy. However, the mechan-
ical behavior of the gastroesophageal junction (GEJ)
after antireflux surgery remains controversial.
The main factors involved in the surgical control
of reflux are (1) the pressure, length, and location of
the LES; (2) the GER valve as defined by the angle of
His and the mucosal flap valve; and (3) the caliber
of the cardia and the length–tension properties of
the gastric sling fibers. The pinchcock action of the
diaphragmatic crura and the reduction in the gastric
capacity of the gastric fundus may also be indirectly
involved in the control of reflux.
Improvement of the LES basal pressure has been
initially suggested as the most relevant effect of fun-
doplication. It has been shown that this effect is
independent of the presence of a native LES, empha-
sizing the role of the tone of the gastricmuscle in the
surgical restoration of LES competence.1 However,
LESP is not the sole determinant of competence.
The interaction of LESP and length of the sphincter
has been extensively studied in an in vitromodel and
it was suggested that the longer the LES, the lower
the LESP required to establish competence.2 In ad-
dition, increasing sphincter length decreases the ef-
fect of gastric wall tension in opening the sphincter,
that is, more gastric distension can occur before an
opening pressure is reached.3
Another mechanism of action of antireflux
surgery is represented by the gastroesophageal flap
or flutter valve, which tends to occlude the lumen
of the distal esophagus as intragastric pressure rises.
The effect of augmentation of the gastroesophageal
mucosal valve can be reached by reducing the an-
gle of His, that results in a more oblique entry of
the esophagus into the stomach, by anchoring the
GEJ to the median arcuate ligament (Hill opera-
tion) or by remodeling theGEJwith a total (Nissen),
partial anterior (Dor), or partial posterior (Toupet)
fundoplication.
Restriction of the caliber of the distal esophagus
is another mechanism that can explain the antire-
flux effect of anoperation.According to the lawof La
Place, the smaller the radius of a tube, the greater the
pressure required to distend it. Therefore, the intra-
gastric pressure required to open the cardia and the
LES is increased by the restriction in esophageal di-
ameterprovidedby the fundoplication.4 Calibration
of the cardia provided by fundoplication results in
improving the mucosal seal and the length–tension
properties of the gastric sling fibers that prevent ef-
facement of the distal esophagus.5,6
In addition, it has been shown that fundoplica-
tion prevents complete relaxation of the LES upon
swallowing and decreases by 50% the triggering of
TLESRs.7 This effect may be the result of reduced
distensibility of the cardia buttressed by the gastric
fundus wall.8
The crural repair which is usually combined with
the antireflux procedure following reduction of a
HH has the potential to prevent mediastinal migra-
tion of the wrap andmay add strength to the antire-
flux barrier.9 Improvement of the gastric emptying
rate is an additional physiological effect of the fun-
doplication that may help in the control of GER. It
is conceivable that a reduction in size of the gastric
reservoir contributes to this effect.10
In summary, the fundoplication restores tone and
length of the LES by extrinsic squeezing, by cali-
brating the cardia, and by optimizing geometry and
biomechanics of theEGJ. It is likely that thenewLinx
refluxmanagement system can interrupt distraction
of the LES by gastric wall tension and therefore in-
crease the intragastric pressure required to open the
cardia.11,12 It is speculated that this effect may be
sufficient to prevent unfolding of the LES and to
provide physiological reflux control in patients with
early disease and small HH.
2. The magnetic sphincter
Luigi Bonavina and Greta I. Saino
luigi.bonavina@unimi.it
Up to 40% of patients with GERD have incomplete
relief of symptoms that cannot be addressed by in-
creasing the daily dose of proton pump inhibitors
(PPIs).13 The laparoscopic Nissen fundoplication is
an effective and durable therapy when performed
in specialized centers, but the level of technical
difficulty and the risk profile have limited its use
to fewer than 30,000 procedures annually in the
United States, corresponding to less than 1% of the
GERDpopulation.14 These factors have contributed
to the propensity of patients to persist with medi-
cal therapy, even when it is inadequate to control
symptoms and complications of the disease such as
31Ann. N.Y. Acad. Sci. 1300 (2013) 29–42 C© 2013 New York Academy of Sciences.
Esophageal surgery Bonavina et al.
Figure 1. Magnetic sphincter augmentation device (Linx) im-
planted around the gastroesophageal junction.
aspiration, esophagitis, and Barrett’s esophagus
(BE).15 As a consequence, a significant gap in the
treatment continuum for GERD remains evident in
current clinical practice.
The Linx reflux management system is designed
to provide a permanent solution to GERD by
augmenting thephysiologic functionof theLESwith
a simple and reproducible laparoscopic procedure
that does not alter gastric anatomyand, importantly,
is easily reversible if necessary. The Linx consists of a
series of titanium beads with magnetic cores sealed
inside. In order for reflux to occur, gastric pressures
must overcome both the patient’s native LESP and
the magnetic bonds of the device.16 The device also
allows for expansion to accommodate a swallowed
bolus or the escape of elevated gastric pressure as-
sociated with belching or vomiting (Fig. 1).
The Linx is implanted laparoscopically under
general anesthesia. By preserving the phrenoe-
sophageal ligament, a tunnel is formed between
the posterior esophageal wall and the posterior va-
gus nerve to accommodate the device. A small HH
(<3 cm) can be repaired at the discretion of the
surgeon. The outer diameter of the esophagus is
measured with a sizing tool and the appropriate
Linx device is implanted and secured. Patients are
discharged on the day of surgery or on the first post-
operative day; they are on a free diet, discontinue the
use of PPIs, and typically return to normal physical
activity in less than aweek. Themost common com-
plaints following the Linx procedure are dysphagia
and chest pain, which are usually well tolerated and
require only temporary diet adjustments.
A prospective controlled and multicenter study
evaluated 44 patients implanted with the Linx be-
tweenFebruary2007andOctober2008.17 Data from
this study were submitted for CE certification and
were determined to have a positive risk-to-benefit
ratio. Subsequent publications reported the 2- and
the 4-year clinical results.11,12,18 The FDAGastroen-
terology and Urology advisory panel voted unan-
imously in March 2012 that there was reasonable
assurance of safety and effectiveness with the use of
the Linx.
Onupper gastrointestinal endoscopy, the impres-
sion of the device was observed in the region of
the GEJ in all patients. There was no increased
resistance to passage of a standard endoscope. A
consistent improvement of quality of life, normal-
ization of reflux, and a dramatic reduction in PPI
use were recorded in these patients. Thirty-two pa-
tients had both baseline and 1-year postoperative
manometric testing. The LES resting pressure in-
creased from 6.5 to 14.6 mmHg (P < 0.005) in
the nine patients with a hypotensive LESP. There
were no statistically significant changes in the length
of the LES nor in the amplitude of esophageal
contractions.
Esophageal pH monitoring was obtained in 20
patients at 1–2 and 3 years after surgery. The mean
total% time pH was <4 decreased from a preop-
erative baseline of 11.9–3.8% (P < 0.001). All of
the other components of the 24-h pH test and the
DeMeester composite score were significantly re-
duced compared to baseline. The esophageal acid
exposure was normalized in 80% of patients.
The mean total GERD–HRQL (health-related
quality of life) score at 4 years or more decreased
to 3.3 compared to the baseline score of 25.7
(P < 0.0001); all patients had at least a 50% reduc-
tion in the total GERD–HRQL score. Interestingly,
87.5% of patients were satisfied with their present
condition, and 80% of patients were free from daily
dependence on PPIs.
To date, nomucosal or transmural erosions of the
device have been reported. Forty-three percent of
patients complained of mild dysphagia during the
postoperative period; in all individuals the symp-
tom resolved by 90 days without treatment. Three
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patients were explanted without operative compli-
cations: one because of persistent dysphagia, one be-
cause of the need to undergo an MRI study, and the
last one who elected to have aNissen fundoplication
for persistingGERD symptoms. Inability to belch or
vomit was reported by less than 5% of patients.
Based upon the clinical experience to date, mag-
netic sphincter augmentation with the Linx reflux
management system provides patients with a per-
manent, easily reversible, and more physiologic so-
lution to their reflux. To date, the device has demon-
strated a high level of efficacy and has met patient
expectations, with few side effects or serious adverse
events.
3. The radiologic characteristics of
antireflux valves following surgery
Demetrio Cavadas
demetrio.cavadas@hospitalitaliano.org.ar
Barium upper gastrointestinal studies provide an
enormous amount of information on the structure
and function of the esophagus and stomach, espe-
cially when the entire examination is recorded on
video rather than as a series of still films. This subject
was opportunely pointed out in a paper by Jeffery
H. Peters, “Modern imaging for the assessment of
GERD begins with the barium esophagogram.”19
The modern barium swallow emphasizes motion
recording (video), uses a tightly controlled exami-
nation protocol, and requires an understanding of
esophageal physiology. The quality of these imaging
results is closely related to careful attention to the
patient’s body position and the technique used in
the examination.19
AnHHis observed in 80%ofpatientswithGERD,
and is best demonstrated in the prone position.
This position increases abdominal pressure andpro-
motes distention of the hernia above the diaphragm.
The finding of a large hernia (>5 cm) or an irre-
duciblehernia in theupperposition is relevant, since
this may suggest the possibility of an esophageal
shortening.
The significanceof radiologicGERvariesdepend-
ing onwhether the reflux is spontaneous or induced
byvariousmaneuvers. Spontaneous reflux isdefined
when it happens with the patient in upright posi-
tion. It is observed by the radiologist in only 40%
of patients with classic symptoms of reflux. When
the radiologist tries to provoke reflux with maneu-
vers, like Valsalva, the idea is to reproduce the rises
of the intra-abdominal pressure that occurs when
the patient makes an abdominal effort, coughs, or
sneezes.19,20
Another important point to stress is that up to
50% of GERD patients have dismotility,21 expressed
by slowing or weakening of primary esophageal
peristalsis, representing a nonspecific motility dis-
order or an ineffective peristalsis. It is important to
be aware that in these patients a retrograde transport
of barium may be mistaken for spontaneous reflux.
Nissen fundoplication is the most common op-
eration for reflux disease worldwide. The esopha-
gogram is a simple, cheap, and well-tolerated study
that allows for a functional and anatomic evalu-
ation of the fundoplication (Fig. 2). Radiologists
should be familiar with normal postfunduplication
findings on contrast material–enhanced studies.
There should be a tapered narrowing of the distal
esophagus that extends for 2–3 cm. The valve should
Figure 2. Radiologic image of Nissen fundoplication.
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be located below the diaphragmatic hiatus,22,23 and
thewrap is seen as a sharplymarginated and smooth
filling defect in the fundus, with the barium column
passing through the center of an image that mimic
a pseudotumor.24
It is not always possible to differentiate between
a Nissen and a modified Toupet fundoplication
by esophagogram. Instead, a Collis gastroplasty
plus Nissen is clearly identified by the image of
the wrap encircling a tube with gastric folds. The
postoperative symptoms that usually require ra-
diographic evaluation include dysphagia, gas bloat
syndrome, and recurrent heartburn. But the assess-
ment of anatomic outcome is essential and should
be done systematically because symptomatic out-
come may underestimate the true recurrence rate.
Complications are generally diagnosed with barium
swallow examination, and include too-tight fundo-
plicationwith delayed clearance, complete or partial
fundoplication dehiscence, recurrent hernia, and
slipped wrap.
Haniaux defines the term intrathoracic migration
of the wrap as a herniation of an intact fundopli-
cation through the hiatus. He emphasizes that it
is an underreported recurrence rate because post-
operative follow-up does not include a systematic
esophagogram.23 He performed radiologic follow-
up yearly in 148 patients after laparoscopic Nissen,
and diagnosed 30% of intrathoracic migrations at
5 years follow-up.
Donkevoort also reported a high rate of anatomic
recurrences. He prospectively investigated 57 pa-
tients after Nissen fundoplication at 2 years follow-
up and with strict radiologic criteria he found that
55% of patients had some degree of anatomic fail-
ure. Curiously, he could not find correlation be-
tween anatomic failure and symptomatic subjec-
tive outcome.24 On the other hand, Italo Braguetto
found a strong association between postoperative
symptoms and different abnormal anatomic defor-
mities in the evaluation with barium swallow.25
In a personal follow-up of 250 consecutive la-
paroscopic Nissen fundoplications for sliding HH,
even when the follow-up was short (4 years) the
symptomatic outcome was excellent (94% of pa-
tients without symptoms), but a very strict pro-
tocol of radiologic follow-up demonstrated 16.4%
of anatomic recurrences, and there was a signif-
icant association between anatomic failure and
symptoms.26
In conclusion, barium esophagogram enhanced
with motion video recording is a very useful diag-
nostic tool to evaluate the morphology and func-
tion of the esophagus, and provides valuable in-
formation for the evaluation of antireflux surgery.
The esophagogramoffers precise information about
the position of the fundoplication and the tran-
sit of the barium through the wrap. The assess-
ment of anatomic outcome with an esophagogram
is simple and should be done systematically because
symptomatic outcome may underestimate the true
recurrence rate.
4. Is there any correlation between
symptoms and endoscopic findings
following antireflux surgery?
Italo Braghetto and Attila Csendes
cirugia@braghetto.cl
After antireflux surgery in patients with GERD, re-
currence of symptoms can occur in near 15–25%
of the patients late after surgery.27–29 The majority
of studies only consider the presence of symptoms,
without performing objective evaluations of the real
antireflux capacity of the surgical procedure. In the
present report we analyze the correlation with the
endoscopic aspect of the antireflux barrier corre-
lated to symptoms and to manometry and 24-h pH
studies.
In a prospective study, we evaluated 120 consec-
utive patients with GERD, excluding patients with
long-segment BE. The objective evaluations were
performed 3–5 years after surgery. Besides clini-
cal questionnaire, manometric and 24-h pH studies
were performed in each patient. They were divided
by endoscopy according to the presence of a normal
or a defective fundoplication after surgery according
to the classification of Seltman and Jobe.30,31
The presence of a normal fundoplication by
endoscopic evaluation was present in 97 patients
(81%). Among them, symptoms of recurrent re-
flux were present in 6%, endoscopic esophagitis in
6%, hypotensive LES in 2%, and abnormal acid re-
flux in 10%. On the contrary, 23 patients (19%)
showed a defective wrap. Among them, recurrent
reflux symptoms were present in 48%, endoscopic
esophagitis in 48%, hypotensive LES in 63%, and an
abnormal acid reflux in 87% (Table 1).
In conclusion, the presence of a normal fundo-
plication late after surgery is associated with 95%
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Table 1. Postoperative radiologic and endoscopic evaluation of anatomic characteristics of cardia and defective
antirefluxbarrier correlated topostoperativemanometry, endoscopic esophagitis, andpostoperative refluxsymptoms
Hypotensive
Abnormal acid sphincter Endoscopic
reflux (<12 mmHg) esophagitis Reflux symptoms
Defective fundopliaction
Radiology (n = 22) 20 (90.9%) 11 (50%) 11 (50%)a 9 (40.1%)a
Endoscopy (n = 23) 20 (86.9%) 15 (62.5%) 11 (47.8%)b 11 (47.8%)b
Normal fundoplication
Radiology (n = 98) 10 (11.3%) 6 (6.1%) 6 (6.1%)a 6 (6.1%)a
Endoscopy (n = 97) 10 (10.3%) 2 (2.1%) 5 (5.1%)b 5 (5.1%)b
aP< 0.001, bP< 0.001.
of good clinical outcome and 90% of normal acid
reflux studies.25,32 On the contrary, when a defec-
tive antireflux wrap is detected, clinical recurrence
is present in only 52% of the patients, but 87% have
an abnormal acid reflux. This means that there is
a very good correlation of a normal postoperative
valve with symptoms and functional studies, but a
poorer correlation if a defective value is present.
5. Lower esophageal sphincter after
sleeve gastrectomy for obese patients
Italo Braghetto and Owen Korn
cirugia@braghetto.cl
Obesity is associated with a statistically
significant increase in the risk of GERD symptoms;
erosive esophagitis, BE, and esophageal carcinoma
progressively increase with increasing weight.32–36
Laparoscopic sleeve gastrectomy has been accepted
as an option for surgical treatment for obesity. After
surgery and this procedure modify the anatomy of
the EGJ, consequently some patients present reflux
symptoms associated with endoscopic esophagitis,
therefore PPI treatment must be indicated. We
have studied the manometric changes and GER
after sleeve gastrectomy. Preoperative mean LESP
was 14.2 ± 5.8 mmHg. After the operation,
LESP decreased significantly to a mean value of
10.5± 6.06mmHg (P= 0.01). Three patients (15%)
presented normal LESP (23.1 ± 3.7 mmHg) and 17
patients (85%) presented hypotensive LES with a
mean LESP of 8.3 ± 2.6 mmHg: six of them (30%)
presented LESP < 6.0 mmHg (5.45 ± 0.5 mmHg)
and 11 patients (55%) presented LESP more than
6.1 mmHg (9.9 ± 1.7 mmHg). All patients had
normal total and abdominal length before the
operation. After sleeve gastrectomy, the abdominal
length and total length of the high-pressure zone at
the EGJ were also affected. Six patients had normal
total and abdominal length of the LES (total length
>3.5 cm and abdominal length >1 cm). Of the
other 14 patients, five patients had total length =
3.5 cm but abdominal length <1 cm and nine
patients had total <3.5 cm and abdominal length
= 0.5 cm (Table 2).37
In addition, associated with these findings we
observed the presence of increased GER with scinti-
graphic assessment, endoscopic erosive esophagitis,
Table 2. Lower esophageal sphincter length before and after sleeve gastrectomy
Before After
LES pressure 14.2 ± 5.8 mmHg 10.5 ± 6.06 mmHg (P = 0.01)
Incompetent LES – 17 (85%)
Normal lengtha 20 6
Incompetent 0 14
Total length>3.5; abdominal length<1 cm 5
Total length<3.5; abdominal length<1 cm 9
aTotal length>3.5; abdominal length>1 cm.
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and cardia dilatation.38 Some authors have sug-
gested that sleeve can be associatedwith severe post-
operative gastroesophageal dysmotility and reflux,
but others have suggested that reflux esophagitis im-
proves after sleeve.39,40 Himpens40 published GERD
appearance de novo in 21.8% of patients after 1 year,
but 3 years later only 3.1% of patients presented
GERD. Petersen41 observed significantly increased
LESP after sleeve gastrectomy, however in the same
paper it is described that gastroscopy demonstrated
cardiac insufficiency, esophagitis, and HH in most
patients. That appears incomprehensible.
In conclusion, sleeve gastrectomy produces im-
portant decrease of LESP, probably due to partial
resection of the sling fibers during the operation.
6. Are outcomes of fundoduplication
in the obese patient population equivalent
to those in the nonobese?
Italo Braghetto
cirugia@braghetto.cl
Many studies have supported the association of
GERD with an increasing BMI reporting that
52% of obese patients present GERD, 53% have
symptoms of GERD, 31% endoscopic esophagitis,
51% positive acid reflux (24-h pH monitoring),
associated with abnormal esophageal acid exposure
in 61% of cases. Erosive esophagitis is 1.25 times
more frequent in obese patients and esophagitis
plus BE is threefold more common. The odds ra-
tio (OR) for GERD in obese patients is 2.6–6.3
with BMI > 35 compared to normal subjects, for
LS-BEs the OR is 4.3, and for adenocarcinoma it
is 16.2. Definitively, GERD is reported to be more
prevalent among the morbidly obese (MO) than
in the general population.33,42 Although some au-
thors disagree with these reports, increasing evi-
dence has suggested that obesity predisposes in-
dividuals to GERD. The evidence that obese pa-
tients who have GERD are at risk of failure of
antireflux procedures is also suggestive but not
conclusive. Most of the available studies have had
low patient numbers and subsequent low statistical
power, or have examined patient populations that
are not selective of the bariatric population (e.g.,
BMI< 35 kg/m2).43–45
Regarding the question: Are outcomes of fundo-
plication in the obese patient population equivalent
to those in the nonobese? The answer is also a con-
troversial point. In several large series, the outcomes
and durability of fundoplication in the setting of se-
vere obesity are not as good as those in patients who
are not severely obese.45 In another study performed
in 224 consecutive patients (3 years follow-up) who
underwent laparoscopic fundoplication, Perez et al.
suggested that obesity adversely affects the outcome
of antireflux operations: overall symptomatic recur-
rencewas 31.3% inobese patients compared to 4.5%
in normal-weight (NW) individuals.46 Morgenthal
demonstrated that obesity is one of the factors pre-
disposing to failure of antireflux procedures, report-
ing 57% failure after fundoplication.47
On the contrary, according to several authors
there are no differences concerning the postoper-
ative outcome comparing normal to obese sub-
jects (Table 3). Campos,48 studying the predictor
factors for failure after fundoplication, concluded
that BMI is not predictive for failure. Anvari49 sug-
gested that obesity is not a contraindication for
antireflux procedures, without deleterious effects
on the postoperative reflux and with very suc-
cessful results after fundoplication, reporting sig-
nificant augmentation of the LESP in MO pa-
tients from 5.96 ± 0.6 to 15.76 ± 1.10 mmHg,
and in NW patients found a similar increase
in LESP from 10.80 ± 0.84 to 19.21 ±
0.82mmHgafter surgery. (P<0.0001 inboth cases).
However, the MO patients reported significantly
higher reflux symptoms scores 6 months postop-
eratively as compared to the NW patients (MO
12.41 ± 1.46 versus NW 4.87 ± 0.69 at 6 months
Table 3. BMI is not predictive for failure postoperative
outcome comparing normal to obese subjects
Failure (%)
BMI< 35
Anvari 4.8
Campos 13
Morgenthal 22
Perez 4.5
Mean ± SD 11.07 ± 8.4
BMI> 35
Anvari 12.1
Campos 14
Morgentahl 57
Perez 31.3
Mean ± SD 28.6 ± 20.8
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postoperative, P< 0.0001). There is no clear expla-
nation for these findings.
Therefore, the question is still open because
many studies have demonstrated a correlation
between failures of antireflux procedures and
increasing BMI, probably because the relative
increase in intra-abdominal pressure associated
with obesity may predispose to fundoplication
breakdown but not necessarily to wrap herniation.
Alternatively, fundoplication breakdown could be
related to technical difficulties inperforming laparo-
scopic antireflux surgery because of the obesity.
More studies are needed to reach a final
conclusion.
7. Paraesophageal hernia repair: is the
use of a biologic mesh superior to a
nonabsorbable mesh?
Edgar J. Figueredo
edfigue@uw.edu
The main principles to obtain an adequate PEH
repair are complete tension-free reduction of the
herniated contents into the abdomen, obtaining an
adequate intra-abdominal esophageal length, com-
plete circumferential excision of the hernia sac, clo-
sure of the hiatus defect, and fixation of the stom-
ach in the subdiaphragmatic position; in addition,
many surgeons advocate the addition of an antire-
flux procedure.50 The closure of the hiatus defect is a
critical step in the PEH repair, and if not performed
is amajor cause of recurrence. Several factors can af-
fect the integrity of the closure. First, the diaphragm
and the crurae undergo significant tension. Second,
themuscular pillars of the cruraemay be attenuated
due to the constant stretch created by the hernia sac.
Third, the size of the hiatal defect ensures significant
tension if only sutures are used to reapproximate the
crurae.51
More recently, the use of prosthetic and biopros-
thetic meshes as a reinforcement of the hiatal re-
pair has gained the acceptance of different groups
in order to decrease the incidence of recurrence.
Frantzides et al.52 compared the incidence of re-
currence of PEH in 72 patients with a hiatal de-
fect greater than 8 cm in diameter, when simple
hiatal closure was used versus polytetrafluoroethy-
lene (PTFE) reinforcement. The study showed eight
recurrences (22%) in the nonmesh group within
6 months, and none in the mesh group. Granderath
et al.53 demonstrated a lower incidenceof recurrence
at 1 year in 50 patients using a mesh compared to
50 patients with primary repair (8% vs. 28%), and
reported the same incidence of dysphagia at 1 year
in both groups. Both studies did not report com-
plications related to the mesh. There have been sev-
eral reports of adverse outcomes associated with the
use of PTFE mesh, and although uncommon, these
complications, such as esophageal, stomach, or GEJ
erosions of the mesh, can severely affect the pa-
tients needing significant surgical interventions.54
Soricelli et al.55 showed that the use of polypropy-
lene mesh in laparoscopic Nissen for patients with
GERD was overall safe in 204 patients, with only
one erosion of the mesh (0.49%); the hernia sac was
used to cover the mesh.
Due to the prosthetic mesh complications, new
bioprosthetic meshes have been used to reinforce
the hiatal closure. These biomaterials act as an ex-
tracellular matrix scaffold to augment the native
tissue healing and regeneration; they are pliable and
temporary, by nature, so they should not have the
associated risks of the nonabsorbable meshes. The
use of these biomaterials appears to be safe, and
it is an effective alternative to the use of synthetic
mesh for PEH repair. Lee et al.56 showed accept-
able recurrence rates (12%) in a group of patients
in whom the hiatal defect was closed with acellular
humandermalmatrixmesh, after an average follow-
up of 14.4 months. A prospective randomized trial
comparing a U-shaped porcine small intestine sub-
mucosa (SIS) mesh reinforcement to primary hiatal
closure, in 106 patients, showed a significantly lower
recurrence rate in the mesh group (9% vs. 24%) at
6 months, assessed by UGI series.57a However,
a follow-up study at 5 years failed to show a
difference,57b but it showed no associated strictures,
erosions, or higher incidence of dysphagia in the
mesh group. The same group published a paper
where 71 patients received a PEH repair with SIS
mesh reinforcement with an average follow-up of
45 months, showing 14 patients with complications
at 30 days, none of them related to the mesh use,
and six patients with dysphagia, also none related
to the mesh. The recommendations for the use of
the biologic mesh are (1) use a U-shapemesh, never
circumferentially placed; (2) cover the posterior hia-
tus, avoiding the sling effect on the esophagus; and
(3) leave a space between the mesh edge and the
esophagus, to avoid excessive contact58 (Fig. 3).
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Figure 3. U-shaped biologic mesh (SIS), placed to reinforce a hiatal closure in a paraesophageal hernia repair.
In conclusion, the use of a biologic mesh can be
safe, and the complications associated with its use
are uncommon. The use of nonabsorbable mesh
might be safe, and although themesh complications
are not common, they can be very serious. The use
of biologic mesh as reinforcement in a PEH repair
compared with a primary repair, does not have any
difference at 5 years in terms of radiologic recur-
rence, but is associated with improvement of the
initial symptoms in patients who underwent a PEH
repair. For these reasons, our group recommends
the use of a biologic mesh.
8. What are the results of endoluminal
antireflux procedures?
Lee L Swanstrom
lswanstrom@aol.com
Multiple endoluminal treatments for GERD have
been developed over the last 15 years—this points to
the need for an intermediate approach to GERD be-
tweenmedication (whichonlyworkswell for 85%of
patients) and laparoscopic fundoplications (which
are expensive and have side effects). Most of the en-
doscopic procedures enjoyed a brief popularity but
then failed in the marketplace and were withdrawn.
Todayonly the transoral incision-less fundoduplica-
tion (TIF) procedure (Endogastric Solutions, Seat-
tle,WA) and the Stretta procedure are commercially
available and in active use. Failure of the procedures
was multifactorial and mainly due to reimburse-
ment issues in theUnitedStates. Theprocedures also
had generally mediocre efficacy, which led to lack
of physician–user enthusiasm and championship.59
In general, all procedures, including the TIF and
Stretta, result in a moderate improvement in symp-
tom scores, some decrease inmedication use, but no
correction of objective acid exposure testing in 70%
or so of patients.60 This has led to some controversy
in the academic community over what exactly the
appropriate endpointofGERDtreatment shouldbe:
patient satisfaction or a normal objective measure-
ment. Another factor leading to poor acceptance has
been the long list of relative contraindications to the
procedures: obesity,HHs, strictures, andBE.61 Since
most patients have one or more of these, practition-
ers quickly develop fatigue in trying to sort out the
fewwhowould benefit from endoluminal treatment
and give up on it.
The Stretta procedure uses radiofrequency burns
to the LES to decrease compliance and perhaps ab-
late some aberrant neural pathways in the cardia
region. Its greatest efficacy has been noted to be in
patients with mild disease, an anatomically normal
LES, anddocumented transient sphincter relaxation
as the cause of the reflux. In these patients, Stretta is
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Table 4. Comparison of TIF results with Nissen and Toupet results
TIF PPIs Nissen Toupet
GERD–HRQL improved by ≥50% 53–86% 68–91% 61–97% 61–97% (from Nissen)
Off daily PPIs 79–85% 0% 79–100% 65–92%
Normal acid exposure 37–67% 50–92% 88–97% 49–94%
Esophagitis reduced 67–80% 84–94% 86–95% 82–89%
Hiatal hernia reduced 60–89% 0% 87–99% 95%
more than 80%effective at correcting reflux. It is hy-
pothesized that the radiofrequency ablation (RFA)
may destroy some of the neural trigger that leads
to abnormal untimed relaxation in these patents.
Overall, patients do not see an elevation of LESP or
substantial normalization of pH studies, but note
improved symptom scores and decreased medica-
tion use.62
The TIF procedure seeks to create a robust an-
tireflux valve by drawing the gastric fundus up to
the esophagus and fastening it with small plastic
tags. Various investigators have found that the en-
doscopic appearance of the resulting valve corre-
lates well with better symptomatic and physiologic
results.63 The procedure has undergone several re-
finements in technique which have improved the
results—currently the TIF2 is recommended that
seeks to wrapmore of the fundus around the esoph-
agus. Once again, the list of relative contraindica-
tions is long and includes obesity, HHs, strictures,
BE, and previous gastric surgery, as well as neck or
esophageal problems that would make it difficult to
pass this rather stiff 60Frenchdevice.Complications
are mainly insertion problems, with several perfo-
rations having been reported, or bleeding from the
fastener placement.64 Bleeding has been reported
in 5–10% of patients. Overall results of the TIF2
show an improved (>50%) symptom score in 80–
85% of patients, a reduction of medications in 75%
(no medications in 40%), and a normalized pH in
around 40% (Table 4).
Conclusion
Physicians and patients continue to ask for a less in-
vasive mechanical option for their GERD. Current
endoluminal devices and procedures havemany pa-
tient exclusions, are disliked by the medical insur-
ance community, and do not normalize pH in the
majority of patients. On the other hand, they do
markedly improve patient symptoms andmaymake
them easier to control medically. Therefore their
place in the GERD treatment repertory remains to
be spelled out and the technologies need to continue
to evolve.
9. Outcomes of revisional antireflux
surgery; surgical and quality of life47,65–73
Eelco Wassenaar
ewassena@uw.edu
Primary antireflux operations have excellent results
with low failure rate. Ten-year follow-up results
show that 85–90% of patients are free of significant
reflux. Over long-term follow-up though, 1–4% of
patients undergo a reoperation. The indication for
reoperation in the majority of cases is recurrent re-
flux (64%). Other reasons are dysphagia (31%), gas
bloat syndrome (3%), and chest pain (2%).
The cause of failure in the majority of patients
is an anatomic abnormality such as recurrent HH
with wrap migration or a problem with the wrap
itself (disruption or disconfiguration). In approx-
imately 2% of patients, failure is found to be due
to a previously unknown motility disorder. These
patients therefore probably should not have under-
gone the initial antireflux procedure.
Primary antireflux operations are safe with very
low mortality (0.2–0.5%) and morbidity (3.8–
7.7%). Length of stay (2–4 days) and conversion
rates (2%or less) are also low.Revisional operations,
as can be expected, have a higher mortality (0.9%)
and morbidity (14–16%) and therefore should not
be taken lightly. Length of stay (5.5 days) and con-
version rates (9%) are also higher.
The outcome of revisional antireflux operations
is nonetheless good, with patients reporting it a
success in 81–84% of cases, which is lower than
after primary repair. Quality-of-life scores are gen-
erally improved as well, although also less improved
compared to after primary repair. When followed
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diligently, up to 33% of patients develop a rerecur-
rent hernia and 5% undergo another operation.
To conclude: a revisional antireflux operation is
feasible but leads to a higher risk of complications,
fewer good results, and a higher risk of failure than a
primary antireflux operation. Therefore it remains
essential to perform a good primary operation after
diligent work-up to try and prevent the necessity of
performing a revisional procedure.
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